1. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3036-7
2. Thuny F, Habib G, Le Dolley Y, et al. Circulating matrix metalloproteinases in infective endocarditis: a possible marker of the embolic risk. PLoS One. 2011;14:6(4):e18830.
3. Daga S, Shepherd JG, Callaghan JG, et al. Platelet receptor polymorphisms do not influence Staphylococcus aureus-platelet interactions or infective endocarditis. Microbes Infect. 2011;13(3):216-25.
4. Weinstock М, Grimm I, Dreier J et al. Genetic Variants in Genes of the Inflammatory Response in Association with Infective Endocarditis PLoS One. 2014;9(10):el 10151.
5. Bustamante J, Tamayo Е, Florez S, et al. Toll-Like Receptor 2 R753Q Polymorphisms Are Associated With an Increased Risk of Infective Endocarditis. Rev. Esp. Cardiol. 2011 ;64(11):1056-9.
6. Ponasenko AV, Kutikhin AG, Khutornaya MV, et al. Inherited Variation in Cytokine, Acute Phase Response, and Calcium Metabolism Genes Affects Susceptibility to Infective Endocarditis. Mediators Inflamm 2017. doi:10.1155/2017/7962546 (4 June 2017).
7. Asopa S, Patel A, Omar A. Khan et al. Non-bacterial thrombotic endocarditis. Eur. J. Cardiothorac. Surg. 2007;32:696-701.
8. Durante-Mangoni E, Iossa D, Nappi F, et al. Inherited hyper-homocysteinemia as a cause of nonbacterial thrombotic endocarditis. Heart Valve Dis. 2011;20(2):232-3.
9. Siddique S, Risse J, Canaud G, et al. Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy? Curr Rheumatol Rep. 2017;19(10):64.
10. Ровенских Д.Н., Максимов В.Н., Татарникова Н.П. и др. Роль молекулярно-генетических факторов в риске развития острого тромбоза глубоких вен нижних конечностей. Бюллетень СО РАМН. 2012;32(4).
11. Man HS, Yan MS, Lee JJ, et al. Epigenetic determinants of cardiovascular gene expression: vascular endothelium. Epigenomics. 2016;8(7):959-79.
12. Alberici F, Martorana D, Vaglio A. Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant. 2015;1:37-45.
13. Rani B, Kumar A, Bahl A, et al. Renin-angiotensin system gene polymorphisms as potential modifiers of hypertrophic and dilated cardiomyopathy phenotypes. Mol Cell Biochem. 2017;27(1-2):1-11.
14. Wang K, Zhu Q, Lu Y, et al. CTLA-4 +49 G/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis. Genet Test Mol Biomarkers. 2017;21(4):222-7